Amgen & Novartis' Alzheimer Studies End in Another Failure science science / science 4 years ago 168 Views comments Amgen (AMGN) and Novartis (NVS) discontinue two Alzheimer's disease studies. Alzheimer's has always been a highly challenging area with many studies failing. Read more
Comments